Use of regadenoson for measurement of fractional flow reserve

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 3, 2014, Pages 369-374

  Prasad, Aditya ^a   Zareh, Meena ^a   Doherty, Reece ^a   Gopal, Ambarish ^a   Vora, Hita ^b   Somma, Keith ^a   Mehra, Anilkumar ^a   Clavijo, Leonardo C ^a   Matthews, Ray V ^a   Shavelle, David M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

atherosclerosis; coronary angiography; fractional flow reserve

Indexed keywords

ATHEROSCLEROSIS; CORONARY ANGIOGRAPHY; FRACTIONAL FLOW RESERVE;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; AGED; CARDIAC CATHETERIZATION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEMODYNAMICS; HUMANS; HYPEREMIA; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PURINES; PYRAZOLES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; VASODILATOR AGENTS;

EID: 84893761451     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25055     Document Type: Article

References (21)

1. Kern MJ, Samady H,. Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol 2010; 55: 173-185.
2. Al JW, Iskandrian AE,. Regadenoson: A new myocardial stress agent. J Am Coll Cardiol 2009; 54: 1123-1130.
3. Botvinick EH,. Current methods of pharmacologic stress testing and the potential advantages of new agents. J Nucl Med Technol 2009; 37: 14-25.
4. Zhao G, Linke A, Xu X, Ochoa M, Belloni F, Belardinelli L, Hintze TH,. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. J Pharmacol Exp Ther 2003; 307: 182-189.
5. Nair PK, Marroquin OC, Mulukutla SR, Khandhar S, Gulati V, Schindler JT, Lee JS,. Clinical utility of regadenoson for assessing fractional flow reserve. JACC Cardiovasc Interv 2011; 4: 1085-1092.
6. Arumugham P, Figueredo VM, Patel PB, Morris DL,. Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve. EuroIntervention 2013; 8: 1166-1171.
7. Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, Anderson WD, Abizaid AA, Mintz GS, Yeung AC, Kern MJ, Yock PG,. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J 2000; 140: 651-657.
8. Bland JM, Altman DG,. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
9. Pijls NH, Tanaka N, Fearon WF. Functional assessment of coronary stenoses: Can we live without it? Eur Heart J 2013; 34: 1335-1344.
10. Tonino PA, De BB, Pijls NH, Siebert U, Ikeno F, Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, Maccarthy PA, Fearon WF,. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360: 213-224.
11. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, Van't VM, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, Maccarthy PA, De BB,. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010; 56: 177-184.
12. De BB, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Mobius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Juni P, Fearon WF,. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012; 367: 991-1001.
13. Ntalianis A, Trana C, Muller O, Mangiacapra F, Peace A, De BC, De BL, Wyffels E, Bartunek J, Vanderheyden M, Heyse A, Van DF, Van DL, De, JJ, Heyndrickx, GR, Wijns, W, Barbato, E, De, BB,. Effective radiation dose, time, and contrast medium to measure fractional flow reserve. JACC Cardiovasc Interv 2010; 3: 821-827.
14. Leone AM, Porto I, De Caterina AR, Basile E, Aurelio A, Gardi A, Russo D, Laezza D, Niccoli G, Burzotta F, Trani C, Mazzari MA, Mongiardo R, Rebuzzi AG, Crea F,. Maximal hyperemia in the assessment of fractional flow reserve: Intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: The NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. JACC Cardiovasc Interv 2012; 5: 402-408.
15. Parham WA, Bouhasin A, Ciaramita JP, Khoukaz S, Herrmann SC, Kern MJ,. Coronary hyperemic dose responses of intracoronary sodium nitroprusside. Circulation 2004; 109: 1236-1243.
16. Rudzinski W, Waller AH, Rusovici A, Dehnee A, Nasur A, Benz M, Sanchez S, Klapholz M, Kaluski E,. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve. Catheter Cardiovasc Interv 2013; 81: 540-544.
17. Wilson RF, White CW,. Intracoronary papaverine: An ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986; 73: 444-451.
18. Jang HJ, Koo BK, Lee HS, Park JB, Kim JH, Seo MK, Yang HM, Park KW, Nam CW, Doh JH, Kim HS,. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. Eur Heart J 2013 [Epub ahead of print].
19. Meimoun P, Sayah S, Tcheuffa JC, Benali T, Luycx-Bore A, Levy F, Tribouilloy C,. Transthoracic coronary flow velocity reserve assessment: comparison between adenosine and dobutamine. J Am Soc Echocardiogr 2006; 19: 1220-1228.
20. Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, Mila R, Tarkin J, Petraco R, Broyd C, Jabbour R, Sethi A, Baker CS, Bellamy M, Al-Bustami M, Hackett D, Khan M, Lefroy D, Parker KH, Hughes AD, Francis DP, Di MC, Mayet J, Davies JE,. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: Results of the ADVISE (A Denosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol 2012; 59: 1392-1402.
21. Johnson NP, Kirkeeide RL, Asrress KN, Fearon WF, Lockie T, Marques KM, Pyxaras SA, Rolandi MC, van', V, De BB, Piek JJ, Pijls NH, Redwood S, Siebes M, Spaan JA, Gould KL,. Does the instantaneous wave-free ratio approximate the fractional flow reserve? J Am Coll Cardiol 2013; 61: 1428-1435.